Medication info
Memantine Tablets 10 mg (Memantine Hydrochloride)

Memantine Tablets 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202004700 · Approved 2020.06.26 · Insurance code 653404660

Summary

Main use
Treatment of moderate to severe Alzheimer’s disease
Who takes it
Adults
Adult dose
Administer orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg daily for 7 days. Week 2 (Days 8~14): Administer 10mg daily for 7 days. Week 3 (Days 15~21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. The recommended maintenance dose is 20mg daily. The recommended dose for elderly patients aged 65 years or older is 20mg daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If tolerated well, the dose may be increased to 20mg daily according to the standard dose-increase schedule, at least 7 days after administration. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer’s disease

View approved original text

This medication is used to treat Alzheimer's disease that ranges from moderate to severe stages. It helps improve memory decline and cognitive function, enhancing the quality of daily life.

How to take

Adult dose

Administer orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7): Administer 5mg daily for 7 days. Week 2 (Days 8~14): Administer 10mg daily for 7 days. Week 3 (Days 15~21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. The recommended maintenance dose is 20mg daily. The recommended dose for elderly patients aged 65 years or older is 20mg daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If tolerated well, the dose may be increased to 20mg daily according to the standard dose-increase schedule, at least 7 days after administration. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication must not be administered to patients who are allergic to any of its ingredients. It should also not be used in patients with severely impaired liver function or very poor kidney function. Caution is warranted when administering to patients with epilepsy or a history of seizures, or those who have a predisposition to seizures. Additionally, co-administration with other drugs that have similar effects should be avoided, as side effects may worsen. Patients with conditions or dietary habits that can change urine acidity (pH) should also be careful, and its safety has not been established in patients with heart disease or uncontrolled hypertension. Possible side effects include dizziness, headache, constipation, drowsiness, and hypertension, and if these symptoms are severe, consultation with healthcare personnel is advised. Because interactions with other drugs may occur, especially with antipsychotic agents, muscle relaxants, anticoagulants, etc., it is crucial to inform the doctor or pharmacist if these medications are being taken. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and it is recommended to stop breastfeeding if nursing. Safety and efficacy have not been confirmed in children and adolescents under 18 years of age, thus, it should not be administered. In the case of overdose, serious symptoms such as confusion, drowsiness, hallucinations, and seizures may occur, requiring immediate medical attention, as there is no specific antidote, and symptomatic treatment will be provided. This medication may affect a patient's concentration and reaction speed; therefore, caution should be exercised when driving or operating machinery. Finally, this medication should be stored out of reach of children and should not be transferred to other containers aside from its original packaging.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 24 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • abnormal comatose state
  • double vision
  • anxiety
  • restlessness
  • psychosis
  • visual hallucination
  • sluggishness
  • unconsciousness
  • weariness
  • lethargy
  • diarrhea
  • anxiety
  • aggression

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it should be kept at room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.